Cargando…
Functioning Endocrine Outcome after Endoscopic Endonasal Transsellar Approach for Pituitary Neuroendocrine Tumors
Background: The endoscopic endonasal approach (EEA) is a well-established technique for the treatment of pituitary neuroendocrine tumor Preservation of normal gland tissue is crucial to retain effective neuroendocrine pituitary function. The aim of this paper is to analyze pituitary endocrine secret...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145377/ https://www.ncbi.nlm.nih.gov/pubmed/37109322 http://dx.doi.org/10.3390/jcm12082986 |
_version_ | 1785034318992637952 |
---|---|
author | Molteni, Gabriele Caiazza, Nicole Fulco, Gianfranco Sacchetto, Andrea Gulino, Antonio Marchioni, Daniele |
author_facet | Molteni, Gabriele Caiazza, Nicole Fulco, Gianfranco Sacchetto, Andrea Gulino, Antonio Marchioni, Daniele |
author_sort | Molteni, Gabriele |
collection | PubMed |
description | Background: The endoscopic endonasal approach (EEA) is a well-established technique for the treatment of pituitary neuroendocrine tumor Preservation of normal gland tissue is crucial to retain effective neuroendocrine pituitary function. The aim of this paper is to analyze pituitary endocrine secretion after EEA for pituitary neuroendocrine tumor to identify potential predictors of functioning gland recovery. Methods: Patients who underwent an exclusive EEA for pituitary neuroendocrine tumors between October 2014 and November 2019 were reviewed. Patients were divided into groups according to postoperative pituitary function (Group 1, unchanged; group 2, recovering; group 3, worsening). Results: Among the 45 patients enrolled, 15 presented a silent tumor and showed no hormonal impairment, and 30 patients presented pituitary dysfunction. A total of 19 patients (42.2%) were included in group 1, 12 (26.7%) patients showed pituitary function recovery after surgery (group 2), and 14 patients (31.1%) exhibited the onset of new pituitary deficiency postoperatively (group 3). Younger patients and those with functioning tumor were more likely to have complete pituitary hormonal recovery (p = 0.0297 and p = 0.007, respectively). No predictors of functional gland worsening were identified. Conclusion: EEA for pituitary neuroendocrine tumor is a reliable and safe technique regarding postoperative hormonal function. Preserving pituitary function after tumor resection should be a primary goal in a minimally invasive approach. |
format | Online Article Text |
id | pubmed-10145377 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101453772023-04-29 Functioning Endocrine Outcome after Endoscopic Endonasal Transsellar Approach for Pituitary Neuroendocrine Tumors Molteni, Gabriele Caiazza, Nicole Fulco, Gianfranco Sacchetto, Andrea Gulino, Antonio Marchioni, Daniele J Clin Med Article Background: The endoscopic endonasal approach (EEA) is a well-established technique for the treatment of pituitary neuroendocrine tumor Preservation of normal gland tissue is crucial to retain effective neuroendocrine pituitary function. The aim of this paper is to analyze pituitary endocrine secretion after EEA for pituitary neuroendocrine tumor to identify potential predictors of functioning gland recovery. Methods: Patients who underwent an exclusive EEA for pituitary neuroendocrine tumors between October 2014 and November 2019 were reviewed. Patients were divided into groups according to postoperative pituitary function (Group 1, unchanged; group 2, recovering; group 3, worsening). Results: Among the 45 patients enrolled, 15 presented a silent tumor and showed no hormonal impairment, and 30 patients presented pituitary dysfunction. A total of 19 patients (42.2%) were included in group 1, 12 (26.7%) patients showed pituitary function recovery after surgery (group 2), and 14 patients (31.1%) exhibited the onset of new pituitary deficiency postoperatively (group 3). Younger patients and those with functioning tumor were more likely to have complete pituitary hormonal recovery (p = 0.0297 and p = 0.007, respectively). No predictors of functional gland worsening were identified. Conclusion: EEA for pituitary neuroendocrine tumor is a reliable and safe technique regarding postoperative hormonal function. Preserving pituitary function after tumor resection should be a primary goal in a minimally invasive approach. MDPI 2023-04-20 /pmc/articles/PMC10145377/ /pubmed/37109322 http://dx.doi.org/10.3390/jcm12082986 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Molteni, Gabriele Caiazza, Nicole Fulco, Gianfranco Sacchetto, Andrea Gulino, Antonio Marchioni, Daniele Functioning Endocrine Outcome after Endoscopic Endonasal Transsellar Approach for Pituitary Neuroendocrine Tumors |
title | Functioning Endocrine Outcome after Endoscopic Endonasal Transsellar Approach for Pituitary Neuroendocrine Tumors |
title_full | Functioning Endocrine Outcome after Endoscopic Endonasal Transsellar Approach for Pituitary Neuroendocrine Tumors |
title_fullStr | Functioning Endocrine Outcome after Endoscopic Endonasal Transsellar Approach for Pituitary Neuroendocrine Tumors |
title_full_unstemmed | Functioning Endocrine Outcome after Endoscopic Endonasal Transsellar Approach for Pituitary Neuroendocrine Tumors |
title_short | Functioning Endocrine Outcome after Endoscopic Endonasal Transsellar Approach for Pituitary Neuroendocrine Tumors |
title_sort | functioning endocrine outcome after endoscopic endonasal transsellar approach for pituitary neuroendocrine tumors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145377/ https://www.ncbi.nlm.nih.gov/pubmed/37109322 http://dx.doi.org/10.3390/jcm12082986 |
work_keys_str_mv | AT moltenigabriele functioningendocrineoutcomeafterendoscopicendonasaltranssellarapproachforpituitaryneuroendocrinetumors AT caiazzanicole functioningendocrineoutcomeafterendoscopicendonasaltranssellarapproachforpituitaryneuroendocrinetumors AT fulcogianfranco functioningendocrineoutcomeafterendoscopicendonasaltranssellarapproachforpituitaryneuroendocrinetumors AT sacchettoandrea functioningendocrineoutcomeafterendoscopicendonasaltranssellarapproachforpituitaryneuroendocrinetumors AT gulinoantonio functioningendocrineoutcomeafterendoscopicendonasaltranssellarapproachforpituitaryneuroendocrinetumors AT marchionidaniele functioningendocrineoutcomeafterendoscopicendonasaltranssellarapproachforpituitaryneuroendocrinetumors |